The stock of Acal plc (LON:ACL) hit a new 52-week low and has GBX 191.84 target or 12.00% below today’s GBX 218.00 share price. The 8 months bearish chart indicates high risk for the GBX 140.06 million company. The 1-year low was reported on Nov, 10 by Barchart.com. If the GBX 191.84 price target is reached, the company will be worth GBX 16.81 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. The stock decreased 0.97% or GBX 2.12 on November 10, hitting GBX 218. About 15,824 shares traded hands. Acal plc (LON:ACL) has declined 12.08% since April 12, 2016 and is downtrending. It has underperformed by 17.73% the S&P500.
Acal plc (LON:ACL) Ratings Coverage
Out of 3 analysts covering Acal PLC (LON:ACL), 3 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. GBX 339 is the highest target while GBX 260 is the lowest. The GBX 304.67 average target is 39.76% above today’s (GBX 218) stock price. Acal PLC has been the topic of 27 analyst reports since July 29, 2015 according to StockzIntelligence Inc. The stock of Acal plc (LON:ACL) has “Buy” rating given on Thursday, April 7 by Peel Hunt. As per Monday, November 30, the company rating was maintained by FinnCap. The stock has “Buy” rating given by Peel Hunt on Friday, November 6. On Friday, April 15 the stock rating was maintained by FinnCap with “Buy”. The rating was maintained by FinnCap with “Buy” on Wednesday, June 1. The stock has “Buy” rating given by Peel Hunt on Thursday, October 13. FinnCap maintained the stock with “Buy” rating in Thursday, November 26 report. The firm has “Buy” rating by FinnCap given on Friday, November 6. The firm has “Buy” rating given on Monday, February 15 by Peel Hunt. FinnCap maintained the stock with “Buy” rating in Thursday, October 13 report.
ACAL plc designs, manufactures and distributes electronic products and solutions. The company has a market cap of 140.06 million GBP. The Firm operates through two divisions: Custom Distribution and Design & Manufacturing. It has a 20.08 P/E ratio. The Custom Distribution segment provides customized electronic, photonic and medical products to the industrial, medical and healthcare markets, both from a range of international suppliers and from the Company’s Design & Manufacturing division.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.